Increased tissue kallikrein amidase activity in urine of patients with type 1 diabetes under insulin therapy, and in those with gestational diabetes mellitus not under insulin therapy

Biochemical and Biophysical Research Communications

Volumn 406, Issue 1, 2011, Pages 141-145

  Miranda, Gilmar Machado ^a   Magalhães, Carolina Antunes ^b   Bosco, Adriana Aparecida ^c   Reis, Janice Sepulveda ^c   Ribeiro Oliveira, Antônio ^d   Nogueira, Anelise Impelizieri ^d   Leite, Ricardo Barsaglini da Silva ^e   Miranda, Paulo Augusto Carvalho ^e   Figueiredo, Amintas Fabiano de Souza ^d  

^a Faculdade Pitágoras de Ipatinga   (Brazil)

^b Prefeitura Municipal de Belo Horizonte   (Brazil)

^c Endocrinologia da Santa Casa de Belo Horizonte   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e Dr Dario de Faria Tavares   (Brazil)

Author keywords

Diabetes mellitus; Gestational diabetes mellitus; Human tissue kallikrein; Kallikrein; Tissue kallikrein; Type 1 diabetes mellitus

Indexed keywords

AMIDASE; CREATININE; HEMOGLOBIN A1C; INSULIN; KALLIKREIN AMIDASE; TISSUE KALLIKREIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; URINALYSIS; URINE FLOW RATE;

ADOLESCENT; ADULT; AMIDOHYDROLASES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; TISSUE KALLIKREINS; YOUNG ADULT;

EID: 79952189672     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.014     Document Type: Article

References (22)

1. Yousef G.M., Diamandis E.P. Tissue kallikreins: new players in normal and abnormal cell growth? Thromb. Haemostasis 2003, 90:7-16.
2. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 1992, 44:1-80.
3. Yousef G.M., Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 2001, 22:184-204.
4. Yousef G.M., Diamandis E.P. Human tissue kallikreins: a new enzymatic cascade pathway? Biol. Chem. 2002, 383:1047-1057.
5. Diamandis E.P., Yousef G.M. Human tissue kallikreins: a family of new câncer biomarkers. Clin. Chem. 2002, 48:1198-1205.
6. Belo A.A., Sousa M.O., Machado E.L.G., Figueiredo A.F.S. On human tissue kallikrein activity in urine of Brazilian White and Black primary hypertensive patients. Ethn. Dis. 2009, 19:265-270.
7. Figueiredo E.L., Leão F.V.G., Oliveira L.V., Moreira M.C.V., Figueiredo A.F.S. The amidase activity of human tissue kallikrein is significantly lower in the urine of patients with systolic heart failure. J. Cardiol. Fail. 2006, 12:653-658.
8. Sacks D.B., Path F.R.C. Carbohydrates. Tietz Textbook of Clinical Chemistry 1994, 928-1001. W.B. Saunders Company, Philadelphia. C.A. Burtis, E.R. Ashwood (Eds.).
9. American Diabetes Association Diagnosis and classification if diabetes mellitus. Diabetes Care 2004, 27(Suppl. 1):S5-S10.
10. Mayfield R.K., Margolius H.S., Levine J.H., Wohltmann H.J., Loadholt C.B., Colwell J.A. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. J. Clin. Endocr. Metab. 1984, 59:278-286.
11. Esmatjes E., Fernandez M.R., Halperin I., Camps J., Gaya J., Arroyo V., Rivera F., Figuerola D. Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins. J. Clin. Endocr. Metab. 1984, 60:1231-1236.
12. Baba T., Murabayashi S., Ishizaki T., Ido T., Aoyagi K., Takebe K. Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy. Diabetologia 1986, 29:162-167.
13. Platts J.K., Meadows P., Jones R., Harvey J.N. The relation between tissue kallikrein excretion rate, aldosterone and glomerular filtration rate in human pregnancy. B.J.O.G. 2000, 107:278-281.
14. Geiger R., Fritz H. Human urinary kallikrein. Methods Enzymol. 1981, 80:466-492.
15. Erlanger B.F., Kokowsky N., Cohen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch. Biochem. Biophys. 1961, 95:271-278.
16. Jaffa A.A., Miller D.H., Bailey G.S., Chao J., Margolius H.S., Mayfield R.K. Abnormal regulation of renal kallikrein in experimental diabetes. J. Clin. Invest. 1987, 80:1651-1659.
17. Jaffa A.A., Chai K.X., Chao J., Chao L., Mayfield R.K. Effects of diabetes and insulin on expression of kallikrein and rennin genes in the kidney. Kidney Int. 1992, 41:789-795.
18. Jaffa A.A., Vio C., Velarde V., LeRoith D., Mayfield R.K. Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat. Diabetes 1997, 46:2049-2056.
19. Pelikánová T., Pinsker P., Smrčková I., Stribrná L., Dryáková M. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus. J. Diabetes Complicat. 1998, 12:264-272.
20. Homko C., Sivan E., Chen X., Reece E.A., Boden G. Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocr. Metab. 2001, 86(2):568-573.
21. Borgoño C.A., Michael I.P., Diamandis E.P. Human tissue kallikreins: physiologic roles and applications in cancer. Mol. Cancer Res. 2004, 2:257-280.
22. Campbell D.J., Gladis A., Zhang Y., Jenkins A.J.J., Prior D.L., Yii M., Kenny J.F., Black M.J., Nelly D.J. Increased tissue kallikrein levels in type 2 diabetes. Diabetología 2010, 53:779-785.